Patient enrolment is a pivotal aspect of any clinical trial. Without a large enough subject group, trial results may lack statistical significance as not enough data has been collected. Beth Cotton & Leslie Jones at WuXi Clinical explains why it is crucial that CROs enrol the desired number of subjects for trials in the agreed timeframes to ensure that the necessary amount of data is collected to determine the safety and/ or efficacy of the drug being assessed.